drugset / Trial / NCT00609531

Functional MRI Evaluation of the Effect of Citalopram in Autism Spectrum Disorders

NCT00609531

RandomizedParallel-groupTriple-blind

Summary

The purpose of this proof of concept study is to use functional magnetic resonance imaging and behavioral assessments to investigate the effect of citalopram on restricted repetitive behaviors in people with autism spectrum disorders.

Timeline

Start
2007-01
Primary completion
2009-08
Completion
2009-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Citalopram Small molecule 5 mg
Subject Citalopram Small molecule 20 mg